Valuation : Zynex, Inc.

Market Cap 3.83M 3.3M 3.09M 2.82M 5.32M 366M 5.34M 36.7M 14.32M 185M 14.38M 14.06M 613M P/E 2023
40.3x
P/E 2024 89x
Enterprise Value 38.02M 32.76M 30.72M 28.04M 52.83M 3.63B 53M 364M 142M 1.83B 143M 140M 6.08B EV / Sales 2023
2.17x
EV / Sales 2024 1.5x
Free-Float
38.37%
Yield 2023 *
-
Yield 2024 -
1 day+5.77%
6 months-31.25%
Current year-56.35%
Current year 0.02
Extreme 0.0203
0.13
1 year 0.02
Extreme 0.0203
2.1
3 years 0.02
Extreme 0.0203
13.77
5 years 0.02
Extreme 0.0203
17.25
10 years 0.02
Extreme 0.0203
27.02
Manager TitleAgeSince
Chief Executive Officer 53 18/08/2025
Director of Finance/CFO 50 18/08/2025
General Counsel 53 18/08/2025
Director TitleAgeSince
Director/Board Member 50 26/03/2026
Director/Board Member 53 26/03/2026
Date Insider Type Main position Quantity % Market Cap.
3/26/26 A Issuer sale

Director

80,001 0.2633%
3/26/26 A Issuer sale

Director

95,000 0.3126%
3/26/26 A Issuer sale

Director

102,000 0.3357%
Change 5-day change 1-year change 3-year change Capi.($)
+5.77%-.--%-96.65%-99.28% 1.69M
-1.35%-1.13%+27.04%+14.12% 230B
+0.18%-1.27%+5.25%-17.37% 152B
+1.51%-1.64%-21.37%+23.59% 132B
+0.36%-7.01%-55.71%-12.92% 67.88B
+0.29%+0.47%+11.06%+18.65% 52B
+0.66%-1.69%-16.57%-13.62% 51.05B
-2.44%-3.25%+23.11%+28.29% 43.38B
-1.56%+0.97%+39.32%+47.34% 40.74B
-5.31%-1.74%+117.39%+36.28% 32.55B
Average -0.21%-3.55%+3.29%+2.51% 80.12B
Weighted average by Cap. -0.46%-1.50%+8.21%+9.30%

Financials

2023 2024
Net sales 184M 159M 149M 136M 256M 17.62B 257M 1.77B 689M 8.89B 692M 677M 29.49B 192M 166M 155M 142M 267M 18.38B 268M 1.84B 719M 9.28B 722M 706M 30.77B
Net income 9.73M 8.39M 7.86M 7.18M 13.52M 930M 13.56M 93.29M 36.4M 470M 36.54M 35.74M 1.56B 2.99M 2.58M 2.42M 2.21M 4.16M 286M 4.17M 28.7M 11.2M 144M 11.24M 11M 479M
Net Debt 31.59M 27.22M 25.52M 23.3M 43.89M 3.02B 44.03M 303M 118M 1.52B 119M 116M 5.05B 34.19M 29.46M 27.63M 25.22M 47.51M 3.27B 47.66M 328M 128M 1.65B 128M 126M 5.47B
Logo Zynex, Inc.
Zynex, Inc. is a medical technology company specialized in the manufacturing and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring. The Company’s devices are intended for pain management to reduce reliance on medications and provide rehabilitation and increased mobility through the utilization of non-invasive muscle stimulation, electromyography technology, interferential current, neuromuscular electrical stimulation and transcutaneous electrical nerve stimulation. The Company’s products include Zynex Medical Products, which includes NexWave, NeuroMove, InWave, E-Wave, M-Wave; Private Labeled Supplies, which includes Electrodes and Batteries; Private Labeled Rehabilitation Products, which include Comfortrac/Saunders, JetStream/Pain Management Technologies, LSO Back Braces, Bracing (Knee and Wrist), and Dynacomp, and Zynex Monitoring Solutions Products, which includes CM-1500, CM-1600, NiCO CO-Oximeter, and HemeOx tHb Oximeter.
Employees
1,000
  1. Stock Market
  2. Stocks
  3. ZYXI Stock